PCRX
Pacira BioSciences, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum inputs (comparable managers):
holder breadth +7.1% ·
share flow +4.6% ·
net new positions +6.7%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 89 | +2 | 30.85M | $781.81M | +7 | −4 |
| Q1 2026 | 89 | -5 | 30.76M | $694.94M | +2 | −7 |
| Q4 2025 | 94 | -1 | 36.25M | $938.05M | — | −1 |
| Q3 2025 | 19 | +1 | 24.74M | $637.46M | +2 | −1 |
| Q2 2025 | 15 | 0 | 22.66M | $541.65M | +1 | −1 |
| Q1 2025 | 12 | -3 | 10.29M | $255.59M | — | −3 |
| Q4 2024 | 15 | +1 | 11.71M | $220.69M | +1 | — |
| Q3 2024 | 13 | 0 | 9.23M | $138.98M | +1 | −1 |
| Q2 2024 | 13 | — | 6.89M | $197.00M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | D. E. Shaw & Co. ✦ | 2.26M | +15.4% | $42.53M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 2 | D. E. Shaw & Co. ✦ | 2.26M | +15.4% | $42.53M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 3 | D. E. Shaw & Co. ✦ | 2.26M | +15.4% | $42.53M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 4 | Renaissance Technologies ✦ | 1.99M | +0.7% | $37.54M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (passive) | 1.97M | — | $37.03M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Millennium Management ✦ | 1.49M | +145.1% | $27.99M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passive) | 1.09M | +0.5% | $20.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passive) | 1.09M | +0.5% | $20.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Point72 Asset Management ✦ | 1.08M | New | $20.27M | 0.1% | New | 1 | SEC ↗ |
| 10 | Arrowstreet Capital ✦ | 647.32K | -43.8% | $12.20M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Wellington Management ✦ | 470.19K | +3.4% | $8.86M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Wellington Management ✦ | 470.19K | +3.4% | $8.86M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Wellington Management ✦ | 470.19K | +3.4% | $8.86M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Wellington Management ✦ | 470.19K | +3.4% | $8.86M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 288.50K | -47.2% | $5.44M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 288.50K | -47.2% | $5.44M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 288.50K | -47.2% | $5.44M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Norges Bank ✦ (passive) | 127.66K | -52.6% | $2.41M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 114.68K | +65.1% | $2.16M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 64.95K | -28.6% | $1.22M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 47.49K | -89.4% | $894,655 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Marshall Wace ✦ | 42.61K | -91.9% | $802,830 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | Marshall Wace ✦ | 42.61K | -91.9% | $802,830 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | T. Rowe Price ✦ | 41.31K | -18.6% | $779,000 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $20.27M | 0.1% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 3 holders, 13.02M shares, $12.57M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.